Table 7.
Immune Cell Subset | FoxP3+ Cells | |||
---|---|---|---|---|
Coefficient | 95% CI | p Value | ||
Sex | Male | Reference | - | - |
Female | −0.0 ± 0.2 | −0.5 to 0.5 | 0.95 | |
Age, years | - | - | 0.57 | |
<55 | Reference | - | - | |
55–64 | −0.3 ± 0.4 | −1.1 to 0.5 | - | |
65–74 | −0.4 ± 0.4 | −1.2 to 0.4 | - | |
75–84 | −0.3 ± 0.4 | −1.2 to 0.5 | - | |
>84 | −0.2 ± 0.5 | −1.2 to 0.8 | - | |
Disease modality (TIA vs. AIS) | −0.4 ± 0.3 | −0.9 to 0.2 | 0.16 | |
National Institutes of Health Stroke Scale | - | - | 0.13 | |
0–4 | Reference | - | - | |
5–9 | 0.3 ± 0.4 | −0.4 to 0.1 | - | |
10–15 | −0.1 ± 0.4 | −0.9 to 0.8 | - | |
>15 | −1.0 ± 0.5 | −2.0 to −0.1 | - | |
Thrombolysis | 0.1 ± 0.3 | −0.5 to 0.7 | 0.80 | |
Use of platelet inhibitor before blood taking | 0.1 ± 0.3 | −0.4 to 0.6 | 0.69 |
AIS, acute ischemic stroke; CI, confidence interval; TIA, transient ischemic stroke; FoxP3 Treg, regulatory T cells.